Stock shortages during the COVID-19 pandemic are about more than just panic buying or labour shortages in supply chains, says UNSW Business School's Professor Jack Cadeaux
Variant-specific vaccines would undoubtedly increase immunity. But waves of new variants would engulf the population faster than these vaccines could ever be deployed.
A team from UNSW's Kirby Institute and St Vincent’s Hospital Sydney have uncovered an immune profile for long COVID, potentially paving the way for tailored treatment for those with ongoing symptoms.
The NSW government’s announcement of a $1000 fine for failing to report a positive voluntary rapid antigen test will likely achieve the opposite of its intention.
The public has been left to their own devices as all our previous safeguards collapse around us. We urgently need a “vaccines-plus” strategy to flatten the curve.
